Shares of PROCEPT BioRobotics Co. ( NASDAQ:PRCT – Get Rating ) have been assigned a consensus recommendation of 'Moderate Buy' from the nine ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $44.38. Several equities research analysts have issued reports on PRCT shares.

https://www.dailypolitical.com/2023/03/06/brokerages-set-procept-biorobotics-co-nasdaqprct-target-price-at-44-38.html

#dailypolitical